Cohera Medical logo — Advancing surgery with innovative, resorbable adhesives and...

Cohera Medical

Advancing surgery with innovative, resorbable adhesives and sealants for safer, more effective procedures.

Founded 2006 11-50 employees Private Equity Total: $49.50M Health Care, Manufacturing +1

General Information

Company Name Cohera Medical
Founded Year 2006
Employees 11-50
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Private Equity
Social

Get notified when Cohera Medical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cohera Medical

Cohera Medical, established in 2006, is a pioneering medical device company that focuses on developing surgical adhesives and sealants. The company's innovative products, including TissuGlu® Surgical Adhesive and Sylys® Surgical Sealant, have gained significant attention in the industry due to their resorbable, non-toxic, and user-friendly chemical design. TissuGlu®, the company's flagship product, has received approval in the U.S. for abdominoplasty procedures and in the EU for use in large flap surgeries. Last investment: $8.40M Series D investment at 26 June 2012 Cohera Medical's diverse product pipeline includes surgical mesh adhesives, hemostatic foam, bone adhesives, and drug delivery systems. The company's focus on addressing critical needs in surgeries, such as minimizing anastomotic leaks and reducing complications in various procedures, positions it well in the rapidly evolving healthcare industry. With ongoing efforts towards gaining further regulatory approvals and expanding their product offerings, Cohera Medical presents an exciting opportunity for investors seeking to support innovative solutions in the medical devices sector.

Taxonomy: medical device company, surgical adhesives, surgical sealants, TissuGlu Surgical Adhesive, Sylys Surgical Sealant, resorbable adhesives, innovative medical devices, CE Mark approval, FDA approval, surgical procedures, abdominoplasty, anastomotic leaks, surgical mesh adhesives, hemostatic foam, drug delivery systems

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• - 26 Jun 2012
Series C •••••• - 19 Dec 2011
Series B •••••• 2
Investor Investor
17 Oct 2008

Cohera Medical Alternatives & Competitors

Cohera Medical vs
EndoGlow
EndoGlow United States

Improving Patient Outcomes by Enhancing Tissue Visualization

5 employees
Manufacturing, Medical Devices
Cohera Medical vs
GEM
GEM Italy

Solution comes from Evolution

33 employees
Manufacturing, Medical Devices
Cohera Medical vs

Pioneering global medical technology since 1999, delivering advanced energy devices for versatile su...

Series Unknown
14 employees
Biotechnology, Health Care

FAQ About Cohera Medical

Advancing surgery with innovative, resorbable adhesives and sealants for safer, more effective procedures.
Cohera Medical was founded in 2006.
Cohera Medical operates in the following industries: Health Care, Manufacturing, Medical Devices.
Cohera Medical has approximately 11-50 employees.
Cohera Medical has completed 3 funding rounds, raising a total of $49.50M. The latest funding stage is Private Equity.
Top alternatives and competitors to Cohera Medical include EndoGlow, GEM, TissueLink Medical, Lizard Health Technology GmbH, LifeBond. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cohera Medical and EndoGlow are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cohera Medical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes